191 related articles for article (PubMed ID: 15523106)
21. Fisetin Enhances Chemotherapeutic Effect of Cabazitaxel against Human Prostate Cancer Cells.
Mukhtar E; Adhami VM; Siddiqui IA; Verma AK; Mukhtar H
Mol Cancer Ther; 2016 Dec; 15(12):2863-2874. PubMed ID: 27765854
[TBL] [Abstract][Full Text] [Related]
22. Insulin-like Growth Factor 1 Signaling Axis Meets p53 Genome Protection Pathways.
Werner H; Sarfstein R; LeRoith D; Bruchim I
Front Oncol; 2016; 6():159. PubMed ID: 27446805
[TBL] [Abstract][Full Text] [Related]
23. A comparison of plasma and prostate lycopene in response to typical servings of tomato soup, sauce or juice in men before prostatectomy.
Grainger EM; Hadley CW; Moran NE; Riedl KM; Gong MC; Pohar K; Schwartz SJ; Clinton SK
Br J Nutr; 2015 Aug; 114(4):596-607. PubMed ID: 26202168
[TBL] [Abstract][Full Text] [Related]
24. Gankyrin drives malignant transformation of chronic liver damage-mediated fibrosis via the Rac1/JNK pathway.
Zhao X; Fu J; Xu A; Yu L; Zhu J; Dai R; Su B; Luo T; Li N; Qin W; Wang B; Jiang J; Li S; Chen Y; Wang H
Cell Death Dis; 2015 May; 6(5):e1751. PubMed ID: 25950481
[TBL] [Abstract][Full Text] [Related]
25. Signaling Pathways in Leiomyoma: Understanding Pathobiology and Implications for Therapy.
Borahay MA; Al-Hendy A; Kilic GS; Boehning D
Mol Med; 2015 Apr; 21(1):242-56. PubMed ID: 25879625
[TBL] [Abstract][Full Text] [Related]
26. Synergistic effect of curcumin on epigallocatechin gallate-induced anticancer action in PC3 prostate cancer cells.
Eom DW; Lee JH; Kim YJ; Hwang GS; Kim SN; Kwak JH; Cheon GJ; Kim KH; Jang HJ; Ham J; Kang KS; Yamabe N
BMB Rep; 2015 Aug; 48(8):461-6. PubMed ID: 25441423
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of 12-lipoxygenase (12-LOX) and plasminogen activator inhibitor 1 (PAI-1) as prognostic markers in prostate cancer.
Gondek T; Szajewski M; Szefel J; Aleksandrowicz-Wrona E; Skrzypczak-Jankun E; Jankun J; Lysiak-Szydlowska W
Biomed Res Int; 2014; 2014():102478. PubMed ID: 24783193
[TBL] [Abstract][Full Text] [Related]
28. miR-Synth: a computational resource for the design of multi-site multi-target synthetic miRNAs.
Laganà A; Acunzo M; Romano G; Pulvirenti A; Veneziano D; Cascione L; Giugno R; Gasparini P; Shasha D; Ferro A; Croce CM
Nucleic Acids Res; 2014 May; 42(9):5416-25. PubMed ID: 24627222
[TBL] [Abstract][Full Text] [Related]
29. Combination of selenium and green tea improves the efficacy of chemoprevention in a rat colorectal cancer model by modulating genetic and epigenetic biomarkers.
Hu Y; McIntosh GH; Le Leu RK; Nyskohus LS; Woodman RJ; Young GP
PLoS One; 2013; 8(5):e64362. PubMed ID: 23717604
[TBL] [Abstract][Full Text] [Related]
30. Evidence for a pro-proliferative feedback loop in prostate cancer: the role of Epac1 and COX-2-dependent pathways.
Misra UK; Pizzo SV
PLoS One; 2013; 8(4):e63150. PubMed ID: 23646189
[TBL] [Abstract][Full Text] [Related]
31. The role of SRC family kinases in prostate cancer.
Tatarov O; Edwards J
Transl Oncogenomics; 2007; 2():67-77. PubMed ID: 23641146
[No Abstract] [Full Text] [Related]
32. Nutrigenomics and cancer.
Ardekani AM; Jabbari S
Avicenna J Med Biotechnol; 2009 Apr; 1(1):9-17. PubMed ID: 23407612
[TBL] [Abstract][Full Text] [Related]
33. Targeting malignant mitochondria with therapeutic peptides.
Constance JE; Lim CS
Ther Deliv; 2012 Aug; 3(8):961-79. PubMed ID: 22946430
[TBL] [Abstract][Full Text] [Related]
34. The role of vitamin D in cancer prevention and treatment.
Krishnan AV; Trump DL; Johnson CS; Feldman D
Rheum Dis Clin North Am; 2012 Feb; 38(1):161-78. PubMed ID: 22525850
[TBL] [Abstract][Full Text] [Related]
35. The 26S proteasome complex: an attractive target for cancer therapy.
Frankland-Searby S; Bhaumik SR
Biochim Biophys Acta; 2012 Jan; 1825(1):64-76. PubMed ID: 22037302
[TBL] [Abstract][Full Text] [Related]
36. The role of vitamin D in cancer prevention and treatment.
Krishnan AV; Trump DL; Johnson CS; Feldman D
Endocrinol Metab Clin North Am; 2010 Jun; 39(2):401-18, table of contents. PubMed ID: 20511060
[TBL] [Abstract][Full Text] [Related]
37. Curcumin enhances dasatinib-induced inhibition of growth and transformation of colon cancer cells.
Nautiyal J; Banerjee S; Kanwar SS; Yu Y; Patel BB; Sarkar FH; Majumdar AP
Int J Cancer; 2011 Feb; 128(4):951-61. PubMed ID: 20473900
[TBL] [Abstract][Full Text] [Related]
38. Curcumin targets FOLFOX-surviving colon cancer cells via inhibition of EGFRs and IGF-1R.
Patel BB; Gupta D; Elliott AA; Sengupta V; Yu Y; Majumdar AP
Anticancer Res; 2010 Feb; 30(2):319-25. PubMed ID: 20332435
[TBL] [Abstract][Full Text] [Related]
39. Targeting anoikis resistance in prostate cancer metastasis.
Sakamoto S; Kyprianou N
Mol Aspects Med; 2010 Apr; 31(2):205-14. PubMed ID: 20153362
[TBL] [Abstract][Full Text] [Related]
40. Microsomal prostaglandin E synthase 1 determines tumor growth in vivo of prostate and lung cancer cells.
Hanaka H; Pawelzik SC; Johnsen JI; Rakonjac M; Terawaki K; Rasmuson A; Sveinbjörnsson B; Schumacher MC; Hamberg M; Samuelsson B; Jakobsson PJ; Kogner P; Rådmark O
Proc Natl Acad Sci U S A; 2009 Nov; 106(44):18757-62. PubMed ID: 19846775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
